Working to Eliminate Inappropriate Antipsychotic Medication Use - PDF document

Jul 25, 2020 •228 likes •266 views

Working to Eliminate Inappropriate Antipsychotic Medication Use Presenter(s): Pauline Kinney, RN, MA, LNHA IPRO NH Team Maureen Valvo Dan Yuricic Dave Johnson QI STRATEGIES Step-By-Step Data Tracking & Monitoring (CASPER) Team

Working to Eliminate Inappropriate Antipsychotic Medication Use Presenter(s): Pauline Kinney, RN, MA, LNHA IPRO NH Team Maureen Valvo Dan Yuricic Dave Johnson QI STRATEGIES Step-By-Step • Data Tracking & Monitoring (CASPER) • Team Approach - Focused Meetings • Ask “Why” ??? • Review System Practices 2 1
MULTI-STEP PROCESS Opportunities for Improvement • Avoid Add-ons - Sustain gains • Pro Active Approach – Recognition & Response • Communication ADDITIONAL RESOURCES Web site www.nursinghomes.ipro.org NHQCC FOCUS ON …. BUILDING BLOCKS FOR QUALITY Learning Essentials Eliminating Inappropriate Antipsychotic Medication Use 4 2
For More Information David L. Johnson, NHA, RAC-CT   Pauline Kinney, RN, MA, LNHA, RAC-CT       Sr. Quality Improvement Specialist Director, Healthcare Quality Improvement Tel: (518) 320-3516 Tel: (516) 209-5402 david.johnson@area-i.hcqis.org pauline.kinney@area-i.hcqis.org Dan Yuricic, MA   Maureen Valvo, RN, BSN, RAC-CT               Sr. Quality Improvement Specialist Sr. Quality Improvement Specialist Tel: (516) 209-5458 Tel: (516) 209-5308 danny.yuricic@area-i.hcqis.org maureen.valvo@area-i.hcqis.org • Team Email IPRO CORPORATE HEADQUARTERS 1979 Marcus Avenue • ipronursinghometeam@ipro.org Lake Success, NY 11042-1002 • Website IPRO REGIONAL OFFICE • www.nursinghome.ipro.org 20 Corporate Woods Boulevard Albany, NY 12211-2370 www.atlanticquality.org   3

Recommend

CARE TALKS Sustaining Practice Now That The Project Is Officially Over More of this And

CARE TALKS Sustaining Practice Now That The Project Is Officially Over More of this And less of this Some History The Unit 75 Long Term Care Beds June 2013: 26% use of inappropriate antipsychotics (1/3 of the unit population)

724 views • 15 slides

Psychotropics and Foster Care: Challenge or Opportunity? Raymond C. Love, PharmD, BCPP, FASHP

Psychotropics and Foster Care: Challenge or Opportunity? Raymond C. Love, PharmD, BCPP, FASHP Professor and Director, Mental Health Program University of Maryland School of Pharmacy Objectives At the conclusion of this presentation, the participant

1.07k views • 57 slides

RI Antipsychotic Med Reduction Challenges to the QIN-QIO 11 th Statement of Work Contract

RI Antipsychotic Med Reduction Challenges to the QIN-QIO 11 th Statement of Work Contract Briefing Presented to the Healthcentric Advisors Board of Directors & Governance Advisory Council June 21, 2017 Task Requirements (63 engaged

259 views • 7 slides

Comparing the Risks and Benefits of Adjunctive Medications for PTSD Presenter Name Beth Cohen,

Comparing the Risks and Benefits of Adjunctive Medications for PTSD Presenter Name Beth Cohen, MD MAS San Francisco VA Health Care System & University of California, San Francisco September 19, 2019 Beth Cohen Has nothing to disclose.

764 views • 22 slides

Atypical Antipsychotics in Phizer Schering-Plough the Pediatric Population Paula Hensley,

6/13/2018 Disclosures Current clinical trial funded by Auspex/Teva Past speakers bureau participation: Janssen Atypical Antipsychotics in Phizer Schering-Plough the Pediatric Population Paula Hensley, MD Acknowledgments

292 views • 4 slides

LATUDA Commercial Update LATUDA Meeting (Tokyo) January 2011 Mark Iwicki President and Chief

LATUDA Commercial Update LATUDA Meeting (Tokyo) January 2011 Mark Iwicki President and Chief Operating Officer Sunovion Pharmaceuticals Inc. Sunovion Is Uniquely Positioned to Deliver Strong Performance for LATUDA Overall market growth is

305 views • 12 slides

Sa fe ly Re duc ing the Use o f Antipsyc ho tic Me dic a tio ns An Ove rvie w Sa ra h C. Sc

Sa fe ly Re duc ing the Use o f Antipsyc ho tic Me dic a tio ns An Ove rvie w Sa ra h C. Sc huma nn Bro o kside Inn T he Qua lity I nitia tive Ame ric a n He a lthc a re Asso c ia tio n (AHCA) a nd CMS T riple Aim: 1. Be tte r He

803 views • 29 slides

CEA Works Well! Large Amounts of Data! UNKNOWN 1 NASCET ECST CEA ACAS Le Roi STENT ACST

QUESTIONS Is carotid artery stenting (CAS) FEASABLE ? Carotid Endarterectomy Is it SAFE ? 1954 - 2006 What are the RESULTS and what are the INDICATIONS ? Is carotid endarterectomy (CEA) DEAD? Is carotid endarterectomy (CEA)

450 views • 12 slides

Anticoagulatie en de oudere patint: Terughoudenheid gerechtvaardigd of niet? 16/06/2018 apr.

Anticoagulatie en de oudere patint: Terughoudenheid gerechtvaardigd of niet? 16/06/2018 apr. Julie Hias Satellite symposium supported by the Alliance BMS/Pfizer 432BE18PR03459/ 180570 (Date of Preparation: June 2018) Overview Introduction

752 views • 20 slides

What Goes Together: Peanut Butter & Jam, Cookies & Milk Antiplatelets &

What Goes Together: Peanut Butter & Jam, Cookies & Milk Antiplatelets & Anticoagulants??? Lily Lin and Kevin Kwok LMPS Pharmacy Residents December 10, 2019 Preceptor: Elaine Lum 1 Learning Objectives Review the mechanism of

1.27k views • 87 slides

Switch of Anti-Platelets: for whom and how? Switch des AAP: pour qui et comment ? Prof. Emanuele

Switch of Anti-Platelets: for whom and how? Switch des AAP: pour qui et comment ? Prof. Emanuele Barbato, MD, PhD, FESC University Federico II, Italy 30-31 Janvier 1 er Fvrier 2019 CONFLICT OF INTERESTS Speakers fee from BSCI and Abbott

776 views • 25 slides

1 2 3 This diagram shows the essence of management which serves as a basis for Otsukas value

1 2 3 This diagram shows the essence of management which serves as a basis for Otsukas value creation model. Under our corporate motto, Otsuka people creating new products for better health worldwide, we have been creating numerous

868 views • 47 slides

Psychosis: an illness of young Improving conditions for recovery: people low-dose antipsychotic

20112015 Psychosis: an illness of young Improving conditions for recovery: people low-dose antipsychotic treatment n First manifestations usually start at 15-25 years of strategies in first episode age psychosis n Incidence around 1.5 :

305 views • 8 slides

Quality of Care in Medi-Cal: Understanding HEDIS for Children in Foster Care Presentation of

Quality of Care in Medi-Cal: Understanding HEDIS for Children in Foster Care Presentation of results for public release April 2019 April 2019 1 Understanding HEDIS Used broadly to measure quality of health care in various systems and

572 views • 42 slides

Supporting people with diabetes and severe mental illness in primary care and the community

Supporting people with diabetes and severe mental illness in primary care and the community Richard IG Holt Professor in Diabetes & Endocrinology DPC 2019 29 October 2019 I have received fees for lecturing, consultancy work or attendance

564 views • 35 slides

Successful Strategies for Implementing the CMS Psychiatric Core Measures Presented by Nola

Successful Strategies for Implementing the CMS Psychiatric Core Measures Presented by Nola Harrison, LCSW St. Anthony Hospital, Oklahoma City Bob Moon, LMSW New York City Heath and Hospitals Corporation 5/7/2013 Successful Strategies for

843 views • 36 slides

APPA 2019 Spring Meeting Resident Poster Presentation Abstract 19 1 01 Title: Reawakening

APPA 2019 Spring Meeting Resident Poster Presentation Abstract 19 1 01 Title: Reawakening Encephalitis Lethargica Authors: Griffin F. Gibson II, MD; Marcus W. Lee, MD Summary: Encephalitis Lethargica (EL) was first described in 1917 by

430 views • 16 slides

Dr Jocelyn Wood General Practitioner Nelson East Family Medical Centre Nelson 11:00 - 11:55 WS

Dr Jocelyn Wood General Practitioner Nelson East Family Medical Centre Nelson 11:00 - 11:55 WS #87: Metabolic Monitoring on Anti-psychotic Medication 12:05 - 13:00 WS #98: Metabolic Monitoring on Anti-psychotic Medication (Repeated)

952 views • 55 slides

Reflections from a Critical Psychiatrist: A way forward for my profession? Sandra Steingard,

Reflections from a Critical Psychiatrist: A way forward for my profession? Sandra Steingard, M.D. Chief Medical Officer, Howard Center Clinical Associate Professor of Psychiatry, University of Vermont Larner College of Medicine A Moment of

636 views • 34 slides

Overview PCMH Advisory Council Meeting April 16, 2019 5/14/2019 1 PCMH Reporting and Data

Office of Medical Assistance Programs Patient-Centered Medical Home (PCMH) Overview PCMH Advisory Council Meeting April 16, 2019 5/14/2019 1 PCMH Reporting and Data Operations Report 19 is an annual report with mandated quarterly

772 views • 11 slides

Phase 2 as Related to the DOH Survey Process Pharmacy Services Richard A. Zelkowitz, RPh, MS,

Phase 2 as Related to the DOH Survey Process Pharmacy Services Richard A. Zelkowitz, RPh, MS, FASCP President, Pharmacon Co. Pharmaceutical Consultants to Health Care Institutions (914) 961-3372 www.PharmaconConsulting.com Phase 2 / DOH

1.07k views • 29 slides

Ellen Garcia MPH and Christina Jaramillo May 1, 2013 Providence ElderPlace is a PACE

Ellen Garcia MPH and Christina Jaramillo May 1, 2013 Providence ElderPlace is a PACE Program of All Inclusive Care for the Elderly. Established in 1990 -one of the 1 st PACE sites Currently serving 1000 frail elders in Multnomah

356 views • 13 slides

Polymedication in nursing home Graziano Onder Centro Medicina dellInvecchiamento Universit

Polymedication in nursing home Graziano Onder Centro Medicina dellInvecchiamento Universit Cattolica del Sacro Cuore Rome - Italy Services and Health for Elderly in Long TERm care (SHELTER) 4156 residents 57 NH 7 EU + Israel Funded

839 views • 39 slides

Disruptive Behavior by Institutional Residents Michael Stones & Stacey Stewart Lakehead

Disruptive Behavior by Institutional Residents Michael Stones & Stacey Stewart Lakehead University & Peter Brink University of Waterloo Abuse and neglect in long-term care is bidirectional. Stones, Stewart, and Kirkpatrick (2003)

725 views • 13 slides